Organization Influence #190 among Organizations

Novo Nordisk

0
24h
0
7 days
▼6
9
30 days
44
All time

Activity (last 30 days)

Activity sparkline for the last 30 days, max 3 mentions in a single day.

Recent Topics AI-generated

  • Novo Nordisk Pursues Once-Daily Pill to Compete With Injections

    29 September 2026 · 2 Sources

  • Novo Nordisk Licenses Chinese Weight-Loss Drug for $2.6 Billion

    29 September 2026 · 2 Sources

  • Germany Blocks Chinese Port Acquisition Amid National Security Concerns

    29 September 2026 · 6 Sources

  • Novo Nordisk Acquires Weight-Loss Pill Rights for Up to $17 Billion

    28 September 2026 · 2 Sources

  • Novo Nordisk Eyes Billion-Dollar Drug

    25 September 2026 · 2 Sources

  • Novo Deal Lifts Danish Stocks But C25 Slips

    24 September 2026 · 2 Sources

  • Novo Nordisk’s stock drums as doubts persist about Ozempic maker’s

    21 September 2026 · 9 Sources

  • Polish Firms Embrace Automation Over Immigration

    21 September 2026 · 3 Sources

  • Novo Nordisk Rebrands to Novo Amid Obesity Market Competition

    14 September 2026 · 5 Sources

  • Denmark Sets 80 GW Offshore Wind Target by 2050

    6 September 2026 · 2 Sources

  • Weight Loss Injections Expand Beyond Obesity Treatment

    17 August 2026 · 3 Sources

  • Prescription Drug Costs Fall to Lowest Level in 60 Years

    17 August 2026 · 2 Sources

  • Nestlé Develops Ozempic Side-Effect Nutrition Products

    17 August 2026 · 3 Sources

  • Former Celebrity Icon Faces Economic Hardship

    12 August 2026 · 2 Sources

  • US Pharma Giant Launches Major Campaign in Danish Capital

    10 August 2026 · 2 Sources

  • Novo Nordisk Weight-Loss Pill Launches in Germany

    7 August 2026 · 2 Sources

  • Fed Rate Guidance Shift Impacts Emerging Market Capital Flows

    6 August 2026 · 2 Sources

  • Novo Nordisk Weight Loss Pill Reshapes Market

    6 August 2026 · 3 Sources

  • Eli Lilly Gains as Novo Nordisk Signals Slowdown

    5 August 2026 · 4 Sources

  • Novo Nordisk Rival Posts Better-Than-Expected Revenue

    5 August 2026 · 2 Sources

  • Novo Nordisk accelerates obesity drug market expansion

    3 August 2026 · 6 Sources

  • Novo Nordisk's Heart Drug Fails Critical Trial Phase

    31 July 2026 · 4 Sources

  • Novo Nordisk Stock Plunges After Failed Clinical Trial

    30 July 2026 · 2 Sources

  • US Pursues GLP-1 Competitor Hims & Hers

    30 July 2026 · 2 Sources

  • Wegovy Weight-Loss Pill Now Available in UK

    6 July 2026 · 2 Sources

  • Medicare Now Covers Obesity Drugs for Seniors

    27 June 2026 · 2 Sources

  • Vestas and Novo Lead Danish Stock Rally

    19 June 2026 · 2 Sources

  • Hackers claim to have stolen Novo Nordisk growth formula

    17 June 2026 · 4 Sources

  • FulcrumSec Claims Major Breach of Novo Nordisk

    16 June 2026 · 3 Sources

  • Healthcare Firm iRhythm Suffers Major Patient Data Breach

    16 June 2026 · 2 Sources

Coverage by Quality Tier

48
A
41
B
3
C
0
D

Top Sources

  • Børsen 18
  • FT Companies 5
  • DR 4
  • Handelsblatt 4
  • Manager Magazin 3
  • CNBC 3
  • WirtschaftsWoche 3
  • Der Standard Wirtschaft 2